The Bioabsorbables/Bioresorbables Center

Filter Your Results

 

News

 

Analysis of ABSORB Trials Evaluates Effect of Technique on Outcomes After BVS Implantation

December 11, 2017 -- An analysis of the effect of technique on outcomes after bioresorbable vascular scaffold (BVS) implantation in the ABSORB trials was published by Gregg W.…

Twelve-Month Results Published From DESSOLVE III Trial of Micell's MiStent

December 6, 2017 -- Micell Technologies, Inc. announced that 12-month results from the DESSOLVE III clinical trial of the company's MiStent, a sirolimus-eluting bioabsorba…

Stentys Begins Precommercialization of Serpentis SES in Europe

November 13, 2017 -- Stentys announced the precommercialization of Serpentis, its new sirolimus-eluting stent, which is composed of a thin cobalt chromium mesh with a bioabsor…

Synergy Stent With Shorter DAPT Compared to BMS in Elderly Patients in SENIOR Trial

November 1, 2017 -- Elderly patients undergoing PCI often receive bare-metal stents (BMSs) instead of drug-eluting stents (DESs) to shorten the duration of dual antiplatelet t…

ABSORB IV Results Show Need for Improvements in BVS Technology and Technique

October 31, 2017 -- Thirty-day results from ABSORB IV randomized everolimus-eluting trial of the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) found the BVS to…

Three-Year ABSORB III Trial Data Presented and Published for Abbott Vascular's BVS

October 31, 2017 -- The ABSORB III study assessed clinical outcomes through 3 years after implantation of the Absorb everolimus-eluting poly-L-lactic acid -- based bioresorbab…

Carag Begins European Marketing After CE Mark Approval for Bioresorbable Septal Occluder  

September 18, 2017 -- Carag AG announced that it has received European CE Mark approval for its Carag bioresorbable septal occluder (CBSO), allowing Carag to fully market the …

Abbott Will Stop Sales of Absorb Bioresorbable Vascular Scaffold System

September 8, 2017 -- Abbott Vascular announced that it will stop selling the first-generation Absorb bioresorbable vascular scaffold system and the Absorb GT1 bioresorbable va…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.